{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:12:58Z","timestamp":1771931578950,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Virtual Real."],"DOI":"10.3389\/frvir.2026.1770918","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:23:02Z","timestamp":1770873782000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Will XR Become the Next Frontier in Healing Substance Use Disorders?"],"prefix":"10.3389","volume":"7","author":[{"given":"Leonardo M.","family":"Angelone","sequence":"first","affiliation":[{"name":"Office of Translational Initiatives and Program Innovations (OTIPI), National Institute on Drug Abuse (NIDA)","place":["Bethesda, MD, United States"]}]},{"given":"Elena","family":"Koustova","sequence":"additional","affiliation":[{"name":"Office of Translational Initiatives and Program Innovations (OTIPI), National Institute on Drug Abuse (NIDA)","place":["Bethesda, MD, United States"]}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","volume-title":"FDA De Novo approval EaseVRx","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s10278-022-00647-4","article-title":"Evaluation challenges for the application of extended reality devices in medicine","volume":"35","author":"Beams","year":"2022","journal-title":"J. Digit. Imaging"},{"key":"B3","unstructured":"Medicare physician fee schedule final rule summary: CY 2026 (MM14315)\n          \n          \n          2026"},{"key":"B4","unstructured":"HCPCS application summary: biannual cycle 2 (non-drug and non-biological items and services)\n          \n          \n          2022"},{"key":"B5","unstructured":"Design considerations for pivotal clinical investigations for medical devices\n          \n          \n          2013"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1017\/S003329171700040X","article-title":"Virtual reality in the assessment, understanding, and treatment of mental health disorders","volume":"47","author":"Freeman","year":"2017","journal-title":"Psychol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.3390\/jcm11216463","article-title":"The effects of virtual reality in targeting transdiagnostic factors for mental health: a systematic review","volume":"11","author":"Gardini","year":"2022","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70144","DOI":"10.1002\/cpp.70144","article-title":"Virtual reality in prevention and treatment of substance-related disorders: a systematic review of randomized controlled trials","volume":"32","author":"Glavak-Tkali\u0107","year":"2025","journal-title":"Clin. Psychol. Psychother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/bs14101431","article-title":"What are the ethical issues surrounding extended reality in mental health? A scoping review of the different perspectives","volume":"14","author":"Goulet","year":"2024","journal-title":"Behav. Sci. (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e49208","DOI":"10.2196\/49208","article-title":"The digital Therapeutics Real-World Evidence Framework: an approach for guiding evidence-based digital therapeutics design, development, testing, and monitoring","volume":"26","author":"Kim","year":"2024","journal-title":"J. Med. Internet Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2024.11.006","article-title":"Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality","volume":"92","author":"Kj\u00e6rstad","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43058-023-00411-1","article-title":"Implementation of virtual reality in healthcare: a scoping review on the implementation process of virtual reality in various healthcare settings","volume":"4","author":"Kouijzer","year":"2023","journal-title":"Implement Sci. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/109493101750527051","article-title":"Immersive virtual environments in cue exposure","volume":"4","author":"Kuntze","year":"2001","journal-title":"Cyberpsychol Behav."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e59409","DOI":"10.2196\/59409","article-title":"Cybersecurity and privacy issues in extended reality health care applications: scoping review","volume":"1","author":"Lake","year":"2024","journal-title":"JMIR XR Spat. Comput."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1613188","DOI":"10.3389\/frvir.2025.1613188","article-title":"Virtual reality-delivered skills-based therapy for chronic lower back pain: from proof-of-concept to FDA authorization to clinical implementation in-home and beyond","volume":"6","author":"Maddox","year":"2025","journal-title":"Front. Virtual Real 6"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13012-020-0977-0","article-title":"Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low- and middle-income countries: a systematic review","volume":"15","author":"Means","year":"2020","journal-title":"Implement Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1517402","DOI":"10.3389\/frvir.2025.1517402","article-title":"Practical considerations of clinical XR (AR\/VR) deployments","volume":"6","author":"Morgan","year":"2025","journal-title":"Front. Virtual Real"},{"key":"B18","unstructured":"NIH reporter project R44DA059475"},{"key":"B19","unstructured":"NIH reporter project R01DA060796"},{"key":"B20","unstructured":"NIH reporter project R43DA059490"},{"key":"B21","unstructured":"NIH reporter project R44DA059018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0140-6736(18)31612-X","article-title":"The Lancet Commission on global mental health and sustainable development","volume":"392","author":"Patel","year":"2018","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e45821","DOI":"10.2196\/45821","article-title":"Medical extended reality trials: building robust comparators, controls, and sham","volume":"25","author":"Persky","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3389\/fnins.2019.01409","article-title":"Virtual Reality (VR) in assessment and treatment of addictive disorders: a systematic review","volume":"13","author":"Segawa","year":"2020","journal-title":"Front. Neurosci."},{"key":"B25","volume-title":"FDA 510(k) clearance","year":"2023"},{"key":"B26","volume-title":"World Drug Report 2024","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"key":"B28","volume-title":"World mental health report: transforming mental health for all","year":"2022"}],"container-title":["Frontiers in Virtual Reality"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frvir.2026.1770918\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:25:30Z","timestamp":1771928730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frvir.2026.1770918\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":28,"alternative-id":["10.3389\/frvir.2026.1770918"],"URL":"https:\/\/doi.org\/10.3389\/frvir.2026.1770918","relation":{},"ISSN":["2673-4192"],"issn-type":[{"value":"2673-4192","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1770918"}}